- Home
- CFSB vs RVNC Comparison
CFSB vs RVNC Comparison
Compare CFSB & RVNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CFSB
- RVNC
- Stock Information
- Founded
- CFSB 1889
- RVNC 1999
- Country
- CFSB United States
- RVNC United States
- Employees
- CFSB N/A
- RVNC N/A
- Industry
- CFSB Major Banks
- RVNC Biotechnology: Pharmaceutical Preparations
- Sector
- CFSB Finance
- RVNC Health Care
- Exchange
- CFSB Nasdaq
- RVNC Nasdaq
- Market Cap
- CFSB 44.7M
- RVNC 320.5M
- IPO Year
- CFSB N/A
- RVNC 2014
- Fundamental
- Price
- CFSB $6.75
- RVNC $3.09
- Analyst Decision
- CFSB
- RVNC Hold
- Analyst Count
- CFSB 0
- RVNC 9
- Target Price
- CFSB N/A
- RVNC $8.45
- AVG Volume (30 Days)
- CFSB 8.9K
- RVNC 3.6M
- Earning Date
- CFSB 01-24-2025
- RVNC 11-07-2024
- Dividend Yield
- CFSB N/A
- RVNC N/A
- EPS Growth
- CFSB N/A
- RVNC N/A
- EPS
- CFSB N/A
- RVNC N/A
- Revenue
- CFSB $7,444,000.00
- RVNC $256,945,000.00
- Revenue This Year
- CFSB N/A
- RVNC $11.28
- Revenue Next Year
- CFSB N/A
- RVNC $27.21
- P/E Ratio
- CFSB N/A
- RVNC N/A
- Revenue Growth
- CFSB N/A
- RVNC 25.82
- 52 Week Low
- CFSB $6.21
- RVNC $2.30
- 52 Week High
- CFSB $7.95
- RVNC $9.75
- Technical
- Relative Strength Index (RSI)
- CFSB 52.19
- RVNC 33.47
- Support Level
- CFSB $6.60
- RVNC $3.06
- Resistance Level
- CFSB $6.82
- RVNC $3.09
- Average True Range (ATR)
- CFSB 0.12
- RVNC 0.11
- MACD
- CFSB 0.01
- RVNC 0.02
- Stochastic Oscillator
- CFSB 79.07
- RVNC 6.90
About CFSB CFSB Bancorp Inc.
CFSB Bancorp Inc provides banking services. It offers a variety of financial services to individuals and small businesses through its offices in Quincy, Holbrook, and Weymouth. Its primary deposit products are savings, checking, and term certificate accounts, and its primary lending product is residential mortgage loans.The Company's loan portfolio includes residential real estate, commercial real estate, construction, and consumer loan segments. Residential real estate loans include classes for one- to four-family, multi-family, second mortgages and home equity lines of credit.
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.